Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

March 2028 88

  1. Study completion Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920640

  2. Study completion Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07929350

  3. Study completion Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684144

  4. Study completion Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06181240

  5. Study completion A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07112339

  6. Primary completion A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07112339

  7. Study completion Post-Stroke Secondary Prevention With Digital Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06837311

  8. Study completion A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07940803

  9. Primary completion A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07940803

  10. Study completion Relevance of Recording an ECG Trace With a Connected Watch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06272396

  11. Primary completion Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07298473

  12. Study completion Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04654988

  13. Study completion the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05126446

  14. Study completion CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05726526

  15. Study completion Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05744219

  16. Study completion Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07253181

  17. Primary completion Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07253181

  18. Primary completion Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04982419

  19. Study completion Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05376267

  20. Primary completion Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05376267

  21. Study completion Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05581303

  22. Primary completion Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05581303

  23. Primary completion Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06337708

  24. Study completion Implementing Food Referrals for Equity and Sustained Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06661538

  25. Study completion A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06679946

  26. Primary completion A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06679946

  27. Study completion Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06705010

  28. Study completion The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06757764

  29. Primary completion The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06757764

  30. Study completion Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06938412

  31. Primary completion Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06938412

  32. Primary completion Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07111559

  33. Study completion Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07143149

  34. Primary completion Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07143149

  35. Study completion Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07389460

  36. Study completion Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07501533

  37. Primary completion Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07501533

  38. Primary completion Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07778823

April 2028 61

  1. Study completion HANGZHOU Solution in Bicuspid AS Undergoing TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04722796

  2. Study completion Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05168462

  3. Primary completion A Study of Renal Microvessel Imaging for Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05764642

  4. Primary completion CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06283888

  5. Study completion Acupuncture for Prediabetes With Combined Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06359418

  6. Study completion Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06634121

  7. Study completion Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06925698

  8. Study completion PROACTIVE-HF IDE Trial Heart Failure NYHA Class III Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04089059

  9. Primary completion PROACTIVE-HF IDE Trial Heart Failure NYHA Class III Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04089059

  10. Study completion Statins for Venous Event Reduction in Patients With Venous Thromboembolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04319627

  11. Study completion DurAVR™ THV System: EMBARK Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05182307

  12. Study completion A Study of Renal Microvessel Imaging for Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05764642

  13. Study completion MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06128629

  14. Study completion Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07028749

  15. Primary completion Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07089576

  16. Study completion BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07118358

  17. Study completion STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07278310

  18. Primary completion STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07278310

  19. Study completion Efficacy and Safety of Compression Boots in Patients With Acute Decompensated Heart Failure. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07377019

  20. Primary completion Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07397845

  21. Primary completion Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07476859

  22. Study completion DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07483801

  23. Study completion Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07537933

  24. Primary completion Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07537933

  25. Primary completion Patient Quality of Recovery After TAVR With Different Sedation Regimens Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07556523

  26. Study completion Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07582835

  27. Primary completion Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07582835

  28. Primary completion Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07656168

  29. Study completion Sphere-9 PAF China Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07789925

  30. Primary completion Sphere-9 PAF China Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07789925

  31. Study completion Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07799129

  32. Primary completion A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07848880

  33. Study completion Study of ALXN2220 Versus Placebo in Adults With ATTR-CM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06183931

  34. Study completion A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06857955

  35. Primary completion A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07775404

  36. Study completion A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07775404

  37. Study completion Atrasentan in Patients With IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04573478

  38. Primary completion Atrasentan in Patients With IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04573478

  39. Study completion A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107945

  40. Primary completion Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04988386

  41. Study completion A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07845682

  42. Primary completion A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07845682

  43. Study completion A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07564414

  44. Study completion Sex-Based Disparities in the Electrophysiological Substrate for Atrial Fibrillation and Its Impact on Clinical Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07580547

  45. Study completion The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06433011

  46. Primary completion The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06433011

  47. Study completion A Study of DII235 in Adults With Elevated Lipoprotein(a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07235046

  48. Primary completion Edwards EVOQUE Eos MISCEND Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02718001

  49. Primary completion Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06225752

  50. Primary completion Second Line Endovascular Treatment in Acute DVT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486181

  51. Study completion Effect of Vagus Nerve Stimulation Via the Outer Ear on Motor and Cognitive Deficits After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822140

  52. Primary completion Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931821

  53. Study completion DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241897

  54. Study completion Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07566065

  55. Study completion Haptic-Assisted Virtual Reality Upper-Limb Rehabilitation After Intracerebral Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07882810

  56. Primary completion Haptic-Assisted Virtual Reality Upper-Limb Rehabilitation After Intracerebral Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07882810

  57. Study completion Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932145

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization Registry record

    Expected 2023-06-04; that period ended on 2023-06-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05670028

  2. Study start Pre-operative Antihypertension Strategies-Carotid Artery Stenting Registry record

    Expected 2023-06-15; that period ended on 2023-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05905848

  3. Study completion Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients Registry record

    Expected 2023-06-26; that period ended on 2023-06-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05226897

  4. Study completion Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02449330

  5. Study completion Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03728738

  6. Study completion Intraosseous Versus Intravenous Vascular Access During Resuscitation Following Out-of-Hospital Cardiac Arrest Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04130984

  7. Study completion Efficacy and Safety of Angong Niuhuang Wan for Stroke Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04236427

  8. Primary completion Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04433533

  9. Study completion An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II) Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04524624

  10. Study completion The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04572724

  11. Study completion Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04657133

  12. Study completion Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04667598

  13. Primary completion Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04684498

  14. Study completion Remote Blood Pressure Management Clinical Application Research Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04690478

  15. Primary completion Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04842838

  16. Primary completion Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04929600

  17. Primary completion Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04967573

  18. Study completion Tangningtongluo Tablet for People With Prediabetes Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05126251

  19. Study completion A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05188417

  20. Primary completion Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05211167

  21. Primary completion Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05263778

  22. Primary completion Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05389254

  23. Study completion Acupoint Stimulation and Cranial Endovascular Treatment Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05413460

  24. Primary completion Acupoint Stimulation and Cranial Endovascular Treatment Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05413460

  25. Primary completion The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426018

  26. Study completion TWIN2WIN (Double Stent (DS-EVT) Versus Primary Thrombectomy With One Stent (SS-EVT)) Registry record

    Expected 2023-06; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05632458

  27. Primary completion Impact of Mobile Phone Application Use on Adult BLS Registry record

    Expected 2023-06-30; that period ended on 2023-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05784675

  28. Primary completion Single vs. Dual-DCCV in Obese Patients Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04539158

  29. Study completion Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04688723

  30. Primary completion Innovative Technologies for the Treatment of Pulmonary and Heart Failure Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05090930

  31. Primary completion Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05421130

  32. Study start Folic Acid Supplementation in Calcific Aortic Valve Disease Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05861648

  33. Study start Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05868564

  34. Study start Effects of Pioglitazone in Calcific Aortic Valve Disease Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05875675

  35. Study start Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05885919

  36. Study start Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05907902

  37. Study start High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05912686

  38. Study start Efficacy and Safety Study: Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Movement Disorders in Patients With Intracranial Hemorrhage (ICH). Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05920473

  39. Study start Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05922644

  40. Study start Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients Registry record

    Expected 2023-07-01; that period ended on 2023-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05927766

  41. Study start Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes Registry record

    Expected 2023-07-10; that period ended on 2023-07-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05950516

  42. Study completion Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients Registry record

    Expected 2023-07-15; that period ended on 2023-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04135287

  43. Study completion Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke Registry record

    Expected 2023-07-15; that period ended on 2023-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04949334

  44. Study start a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Registry record

    Expected 2023-07-15; that period ended on 2023-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05922436

  45. Primary completion Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD Registry record

    Expected 2023-07-28; that period ended on 2023-07-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580510

  46. Study completion Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement Registry record

    Expected 2023-07-30; that period ended on 2023-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03557242

  47. Primary completion Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement Registry record

    Expected 2023-07-30; that period ended on 2023-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03557242

  48. Primary completion Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease Registry record

    Expected 2023-07-30; that period ended on 2023-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05203484

  49. Study completion ROBOtic Care of Post-stroke Pain. Registry record

    Expected 2023-07-30; that period ended on 2023-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05288270

  50. Study completion The Safety and Efficacy of the Suture-Mediated Closure System Registry record

    Expected 2023-07-30; that period ended on 2023-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05841836

  51. Primary completion Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment Registry record

    Expected 2023-07; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01620788

  52. Study completion Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism Registry record

    Expected 2023-07; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01848171

  53. Primary completion Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism Registry record

    Expected 2023-07; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01848171

  54. Study completion Neural Mechanisms and Efficacy of Dual Neurotechnology-aided Mirror Therapy in Chronic Stroke: Neural and Motor Plasticity, Movement Performance, Daily Function, and Quality of Life Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04326205

  55. Primary completion Neural Mechanisms and Efficacy of Dual Neurotechnology-aided Mirror Therapy in Chronic Stroke: Neural and Motor Plasticity, Movement Performance, Daily Function, and Quality of Life Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04326205

  56. Primary completion Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04419337

  57. Study completion Single vs. Dual-DCCV in Obese Patients Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04539158

  58. Study completion MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04604587

  59. Primary completion MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04604587

  60. Primary completion Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease Registry record

    Expected 2023-07-31; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04939116

  61. Primary completion Rotablation vs Intravascular Lithotripsy in Calcified Coronary Lesions Registry record

    Expected 2023-07; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04960319

  62. Study start DIAbetes Maximal ACCeleration Registry record

    Expected 2023-07; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646147

  63. Study start Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke Registry record

    Expected 2023-07; that period ended on 2023-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910125

  64. Study completion Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation. Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04009434

  65. Primary completion Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation. Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04009434

  66. Primary completion Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05110898

  67. Study completion Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial Fibrillation Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466266

  68. Primary completion Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial Fibrillation Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466266

  69. Primary completion Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691257

  70. Study start Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer Registry record

    Expected 2023-08-01; that period ended on 2023-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05976893

  71. Study start Vibration Approach Functions in Upper Extremities for People After Stroke Registry record

    Expected 2023-08-07; that period ended on 2023-08-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05969249

  72. Primary completion Research on Diagnosis and Prognosis of Myocardial Ischemia Level Using Magnetocardiography Registry record

    Expected 2023-08-14; that period ended on 2023-08-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05718206

  73. Study start Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI Registry record

    Expected 2023-08-18; that period ended on 2023-08-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05982470

  74. Study start First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation Registry record

    Expected 2023-08-21; that period ended on 2023-08-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05939076

  75. Primary completion The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling Registry record

    Expected 2023-08-25; that period ended on 2023-08-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05000411

  76. Primary completion The JenaValve ALIGN-AR Pivotal Trial Registry record

    Expected 2023-08-29; that period ended on 2023-08-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04415047

  77. Study completion BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02190500

  78. Primary completion A Polypill for Secondary Prevention of Ischemic Heart Disease Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03541109

  79. Study completion Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03811691

  80. Study completion Smartphone-based Balance Assessment System for Chronic Stroke Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04040101

  81. Study completion Prevention of Post-Operative Cardiac Arrhythmias Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04234906

  82. Primary completion Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC) Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04239391

  83. Study completion The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes: CLEAR Study Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04514562

  84. Primary completion The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes: CLEAR Study Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04514562

  85. Study completion Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study) Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04737408

  86. Primary completion Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study) Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04737408

  87. Study completion Study of Roxadustat in the Treatment of Acute Myocardial Infarction Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04803864

  88. Study completion Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04939116

  89. Primary completion Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04974333

  90. Primary completion Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection Registry record

    Expected 2023-08; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05430672

  91. Study completion Impact of Mobile Phone Application Use on Adult BLS Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05784675

  92. Primary completion Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2 Registry record

    Expected 2023-08-31; that period ended on 2023-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05843682

  93. Study completion Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04171726

  94. Study completion Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04714177

  95. Primary completion Echocardiography by Non-cardiologist in Early Management of Patients With Chest Pain Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05306730

  96. Study completion Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05354297

  97. Study start Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect) Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05893199

  98. Study start Mobile Cardiac Outpatient Telemetry for Unexplained Syncope Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05957315

  99. Study start Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System Registry record

    Expected 2023-09-01; that period ended on 2023-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05974306

  100. Study completion Clinical Trial of C-Wave™ Peripheral Lithoclasty System Catheter System Registry record

    Expected 2023-09-08; that period ended on 2023-09-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05435716